Indimacis 125 |
Human |
igovomab |
igovomab |
EMEA/H/C/000065 |
CIS bio international |
1996/10/04
|
Withdrawn |
CEA-Scan |
Human |
arcitumomab |
arcitumomab |
EMEA/H/C/000041 |
Immunomedics GmbH |
1996/10/04
|
Withdrawn |
Invirase |
Human |
saquinavir |
saquinavir |
EMEA/H/C/000113 |
Roche Registration GmbH |
1996/10/03
|
Withdrawn |
Zyprexa |
Human |
olanzapine |
olanzapine |
EMEA/H/C/000115 |
CHEPLAPHARM Registration GmbH |
1996/09/27
|
Authorised |
Twinrix Adult |
Human |
hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
hepatitis A virus (inactivated);hepatitis B surface antigen |
EMEA/H/C/000112 |
GlaxoSmithKline Biologicals S.A. |
1996/09/19
|
Authorised |
Tecnemab K1 |
Human |
anti-melanoma mab fragments |
anti-melanoma mab fragments |
EMEA/H/C/000068 |
Amersham Sorin.S.r.l. |
1996/09/05
|
Withdrawn |
Rapilysin |
Human |
reteplase |
reteplase |
EMEA/H/C/000105 |
Actavis Group PTC ehf |
1996/08/29
|
Authorised |
Ecokinase |
Human |
reteplase |
reteplase |
EMEA/H/C/000106 |
Roche Registration Ltd. |
1996/08/29
|
Withdrawn |
Norvir |
Human |
ritonavir |
ritonavir |
EMEA/H/C/000127 |
AbbVie Deutschland GmbH Co. KG |
1996/08/25
|
Authorised |
Epivir |
Human |
lamivudine |
lamivudine |
EMEA/H/C/000107 |
ViiV Healthcare BV |
1996/08/08
|
Authorised |
Tritanrix HepB |
Human |
diphtheria (D), tetanus (T), pertussis (whole cell) (Pw) and hepatitis B (rDNA) (HBV) vaccine (adsorbed) |
Diphtheria toxoid;hepatitis B surface antigen;Bordetella pertussis (inactivated);tetanus toxoid |
EMEA/H/C/000093 |
GlaxoSmithKline Biologicals S.A. |
1996/07/19
|
Lapsed |
Bondronat |
Human |
ibandronic acid |
ibandronic acid |
EMEA/H/C/000101 |
Atnahs Pharma Netherlands B.V. |
1996/06/25
|
Authorised |
Destara |
Human |
ibandronic acid |
ibandronic acid |
EMEA/H/C/000103 |
Roche Registration Ltd. |
1996/06/25
|
Withdrawn |
Caelyx pegylated liposomal |
Human |
doxorubicin |
doxorubicin hydrochloride |
EMEA/H/C/000089 |
Baxter Holding B.V. |
1996/06/20
|
Authorised |
Rilutek |
Human |
riluzole |
Riluzole |
EMEA/H/C/000109 |
Sanofi Winthrop Industrie |
1996/06/10
|
Authorised |
Zerit |
Human |
stavudine |
stavudine |
EMEA/H/C/000110 |
Bristol-Myers Squibb Pharma EEIG |
1996/05/08
|
Withdrawn |
Puregon |
Human |
follitropin beta |
follitropin beta |
EMEA/H/C/000086 |
N.V. Organon |
1996/05/02
|
Authorised |
Humalog |
Human |
insulin lispro |
insulin lispro |
EMEA/H/C/000088 |
Eli Lilly Nederland B.V. |
1996/04/30
|
Authorised |
Porcilis Porcoli Diluvac Forte (previously Porcilis Porcoli) |
Veterinary |
vaccine to provide passive immunity to the progeny against E. coli in pigs |
F4ab (K88ab) fimbrial adhesin;F4ac (K88ac) fimbrial adhesin;F5 (K99) fimbrial adhesin;F6 (987P) fimbrial adhesin;LT toxoid |
EMEA/V/C/000024 |
Intervet International BV |
1996/02/29
|
Authorised |
NovoSeven |
Human |
eptacog alfa (activated) |
eptacog alfa (activated) |
EMEA/H/C/000074 |
Novo Nordisk A/S |
1996/02/23
|
Authorised |